News & Events

News &

Tarsier Pharma Announces Presentation At The 12th Annual Congress of the Israeli Ophthalmological Society (IOS)

June 4-5, 2024

We are excited to announce that Dr. Ron Neumann, Chief Medical Officer, will be presenting at the 12th Annual Israeli Ophthalmology Society Conference. Dr. Neumann will discuss the Phase III Trial TRS01, focusing on the efficacy and safety of our novel non-steroid treatment for active noninfectious anterior uveitis and uveitic glaucoma.

Presentation details:

  • Session: Uveitis
  • Date: June 4, 2024
  • Time: 08:24 t0 8:30am  PT
  • Location: David Intercontinental Hotel, Tel Aviv, Israel


Scroll to Top